The brightest minds in the CDMO industry.

From early development through to commercial manufacturing.


Recipharm AB publishes its report for the fourth quarter and full year 2017


Whether you’re a large or small pharmaceutical company, our talented team can develop and transform your promising molecule into a product. We’ve supported many clients over the years, and you can be next.

Torkel Gren - General Manager

“Recipharm takes responsibility for the full phase I programme, from formulation to clinical trial implementation with patients.”


With production facilities across the world covering a range of product types and dosage forms, you can count on our manufacturing expertise to reliably deliver your product on time, every time. Shall we get started?

Ann Flodin - General Manager

"We are focused on managing complexity for our customers, this means providing a full service offering to simplify the supply chain."

Meeting your serialisation challenge

The CDMO will be ready to pack serialised products from 1 January 2018.



White paper

Drug solubility

Utilising a high throughput screening platform to determine the optimum pharmaceutical excipients in the development of liquid formulations.

Need a CDMO partner?

Developing pharmaceuticals can be a tricky business, so let us help.